Purchase Order HHSN269201600846P
Award Date 9/29/16
Potential Completion Date 12/31/18
Potential Value $629K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The NIH Clinical Center awarded a delivery order to Becton, Dickinson and Company's Infectious Disease Systems division for a Reagent Rental Agreement Option 1 valued at $300,000 with a firm fixed price structure. The contract, which commenced January 1, 2026 and extends through December 31, 2026, will be performed at the NIH Clinical Center facility in Bethesda, Maryland. This award was issued without a set-aside designation, reflecting BD's competitive position as an established large business...
- <p>The NIH Clinical Center awarded a purchase order to Becton, Dickinson and Company (BD Biosciences division) on April 20, 2026, for one-time onsite inspection service agreements, with a ceiling value of $60,000.00 and ultimate completion date of April 19, 2027. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside.</p>
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Becton, Dickinson and Company on January 26, 2018, for $5,245.60, with ultimate completion on February 9, 2018. The order was placed on a firm fixed price basis with no set-aside. Place of performance is Bethesda, Maryland. The source does not specify the commodities or services procured under this order.</p>
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a Firm Fixed Price purchase order to Becton, Dickinson and Company (BD), a manufacturer of medical devices, instruments, and reagents. The $38,920.00 contract is for BD reagents to be used for single-cell abseq analysis on BD Rhapsody instruments in the PACT section of the Clinical Center. The contract has an August 30, 2024 completion date and was awarded on May 15, 2024. This purchase order is not...
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Becton, Dickinson and Company, Infectious Disease Solutions Division, valued at $20,501.76 on June 4, 2018, with ultimate completion on August 7, 2019. Performance takes place in Bethesda, Maryland. The order is a firm fixed price procurement with no set-aside designation. The specific goods or services procured are not detailed in the source material.</p>
- <p>The NIH Clinical Center awarded a purchase order to Becton, Dickinson And Company for $17,566.44 on May 13, 2019, with ultimate completion by September 18, 2020. Place of performance is Bethesda, Maryland. The order is a firm fixed-price acquisition with no set-aside designation. The source does not specify the scope of supplies or services procured.</p>
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $100,000 firm fixed price delivery order to Becton, Dickinson and Company IDS Division for the purpose of funding a reagent rental agreement from January 1, 2024 through December 31, 2024. BD Diagnostic Systems, operating as the prime contractor, will provide clinical laboratory reagents to support research activities at the NIH Clinical Center over the one-year period of performance. No...
- The National Institutes of Health Clinical Center issued a delivery order to Becton, Dickinson and Company on February 24, 2020, with a ceiling value of $33,745.00 for medical equipment and supplies. The order was placed under the company's existing Indefinite Delivery Contract with the NIH Clinical Center, valued at $1.25 million through December 31, 2026, with optional extensions through 2029. This IDC authorizes procurement of BD instrumentation packages, reagent kits, quality control...
- Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health Clinical Center. Valued at eleven thousand six hundred seventy-one dollars and sixty cents ($11,671.60), this award is for the RHAPSODY Targeted mRNA ABSEQ Kit. Delivery is required by February 23, 2024. As a manufacturer and supplier of medical devices, instruments, reagents, and related products, BD will provide the requested...
- The National Institutes of Health Clinical Center awarded a purchase order to Becton, Dickinson and Company, Infectious Disease Systems division, for $5,524.43 on February 14, 2018, with completion by December 31, 2018. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no set-aside applied. The purchase procures medical diagnostic equipment, laboratory instrumentation, reagents, or related supplies supporting the Clinical Center's laboratory and clinical...
The NIH Clinical Center awarded a purchase order to Becton, Dickinson and Company for BD reagent rental agreement covering various BD reagents, kits, supplies, and consumables, with a ceiling value of $629,198.12 and an award date of September 29, 2016. Place of performance is Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of December 31, 2018. No small business set-aside was used.
Generated 6/4/26, 12:06 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00009 | Funding Only Action | ($110) | 9/24/24 | |
| P00008 | Funding Only Action | ($6k) | 9/7/24 | |
| P00007 | Funding Only Action | ($11k) | 9/22/23 | |
| P00006 | Supplemental Agreement for work within scope | $10.0k | 11/30/18 | |
| 5 | Supplemental Agreement for work within scope | $40.0k | 8/29/18 |